View Older Stories View More Recent Stories

Jan 5, 2023 09:00AM Jnana Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Jan 5, 2023 08:00AM MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Jan 5, 2023 03:00AM Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform
Jan 4, 2023 08:00PM Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Dec 30, 2022 04:58PM Form SC 13D/A Achilles Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 30, 2022 04:30PM Form SC 13G Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 23, 2022 05:16PM Form SC 13D/A Achilles Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 15, 2022 05:03PM Form SC 13D/A Achilles Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 12, 2022 07:30AM Celcuity Closes $100 Million Private Placement
Dec 9, 2022 04:31PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 8, 2022 06:30AM Be Biopharma Appoints John Mayfield, Ph.D., as Chief Business Officer
Dec 7, 2022 04:00PM Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer
Dec 7, 2022 07:45AM Vor Biopharma (VOR) Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
Dec 7, 2022 07:45AM Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
Dec 7, 2022 06:30AM Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
Dec 5, 2022 05:12PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 5, 2022 07:33AM Solid Biosciences (SLDB) Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
Dec 5, 2022 07:30AM Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
Dec 2, 2022 04:31PM Form SC 13G NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 28, 2022 05:16PM Research Alliance Corp. II Will Redeem Public Shares
Nov 28, 2022 04:46PM Form SC 13D Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 23, 2022 08:03AM NewAmsterdam Pharma (NAMS) Debuts as Publicly Traded Company
Nov 23, 2022 08:00AM NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential
Nov 23, 2022 08:00AM NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential
Nov 22, 2022 10:49AM Empatica receives new FDA clearance for its Health Monitoring Platform and announces Series B financing
Nov 22, 2022 08:45AM Exo® CFO Lori Munoz Wins Stevie Award for Women in Business
Nov 22, 2022 08:45AM Exo® CFO Lori Munoz Wins Stevie Award for Women in Business
Nov 17, 2022 10:00AM Scribe Therapeutics to Participate in Four Upcoming Conferences
Nov 16, 2022 10:00AM Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines
Nov 16, 2022 08:30AM Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
Nov 15, 2022 09:00AM Adela's Co-Founder & Chief Scientific Officer to Deliver Plenary Session at American Association for Cancer Research (AACR) Special Conference on Precision Prevention, Early Detection, and Interce
Nov 15, 2022 08:00AM CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline
Nov 15, 2022 06:00AM Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases
Nov 15, 2022 06:00AM Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Nov 14, 2022 04:47PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A LianBio Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A VERU INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Xilio Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Olema Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A OTONOMY, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A STANDARD BIOTOOLS INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:44PM Form SC 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2022 04:40PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 14, 2022 04:01PM Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
Nov 14, 2022 04:01PM Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
Nov 14, 2022 08:00AM MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
Nov 8, 2022 04:04PM ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
View More Recent Stories View Older Stories